UBA1 (Ubiquitin-Like Modifier Activating Enzyme 1, also known as UBE1; encoded by the UBA1 gene is the primary E1 ubiquitin-activating enzyme in human cells. It catalyzes the first step of the ubiquitination cascade, making it the master initiator of the ubiquitin-proteasome system.
UBA1 is a 117 kDa monomeric enzyme that activates ubiquitin through an ATP-dependent mechanism, forming a thioester intermediate before transferring ubiquitin to E2 conjugating enzymes[1]. As one of only two E1 enzymes for ubiquitin in mammals (along with UBA6), UBA1 is responsible for the vast majority (~99%) of cellular ubiquitination[2]. Its central position in proteostasis makes UBA1 activity critical for neuronal health and a convergence point in neurodegenerative disease mechanisms.
[^2]
| | |
|---|---|
| Protein Name | UBA1 (UBE1, E1 ubiquitin-activating enzyme) |
| Gene | UBA1 |
| UniProt ID | P22314 |
| Molecular Weight | 117 kDa (UBA1a), 110 kDa (UBA1b) |
| Length | 1,058 amino acids |
| Subcellular Localization | Nucleus (UBA1a), Cytoplasm (UBA1b) |
| Function | E1 ubiquitin-activating enzyme |
¶ Domain Architecture
UBA1 has a multi-domain architecture optimized for ubiquitin activation and transfer[1]:
- Inactive adenylation domain (IAD): N-terminal; structural role, no catalytic activity
- Active adenylation domain (AAD): Contains the ATP-binding site; catalyzes ubiquitin adenylation
- First catalytic cysteine half-domain (FCCH): Part of the catalytic core
- Second catalytic cysteine half-domain (SCCH): Contains the catalytic Cys632 that forms the thioester with ubiquitin
- Ubiquitin fold domain (UFD): C-terminal; recruits and interacts with E2 enzymes
The UBA1 reaction proceeds through a three-step mechanism[2]:
- Ubiquitin adenylation: ATP + Ub → Ub-AMP + PPi (in the AAD)
- Thioester formation: Ub-AMP + UBA1-Cys632 → UBA1~Ub + AMP (in the SCCH)
- Transthiolation: UBA1~Ub + E2-Cys → E2~Ub + UBA1 (via UFD/E2 interaction)
UBA1 can simultaneously hold two ubiquitin molecules: one as adenylate in the AAD and one as thioester on Cys632.
UBA1 charges approximately 30-35 E2 ubiquitin-conjugating enzymes[3], including:
- UBE2D family: General-purpose E2s for proteasomal targeting
- UBE2N/UBE2V: K63-linked chain assembly for signaling
- UBE2S: K11-linked chains for cell cycle regulation
- UBE2K: Works with E3 ligases for neurodegenerative protein clearance
- UBE2R1: SCF complex-associated E2
UBA1 is critical for maintaining proteostasis in neurons[4]:
- Misfolded protein clearance: Initiates ubiquitin tagging for proteasomal degradation of aggregation-prone proteins (tau, α-synuclein, TDP-43
- Synaptic protein turnover: Ubiquitin-dependent degradation of synaptic proteins regulates plasticity
- Mitophagy initiation: Ubiquitination of outer mitochondrial membrane proteins by Parkin requires UBA1-activated ubiquitin
- ER quality control: ERAD pathway depends on UBA1 for retrotranslocation and degradation of ER-misfolded proteins
UBA1 activity decreases with aging, contributing to proteostasis collapse[4]:
- 30-50% reduction in UBA1 protein levels in aged rodent brains
- Reduced ubiquitin conjugation capacity in aged neurons
- Correlates with accumulation of ubiquitin-positive inclusions
- May represent an upstream driver of age-related neurodegeneration
- Alzheimer's disease: Reduced UBA1 in AD hippocampus; impaired ubiquitination of tau contributes to tangle formation
- Parkinson's disease: UPS overwhelmed by α-synuclein aggregates; UBA1 activity insufficient for clearance
- Motor neuron disease: UBA1 loss-of-function causes X-linked infantile SMA; motor neurons are especially dependent on UPS
- Polyglutamine diseases: Expanded polyQ proteins sequester UBA1 and ubiquitin, depleting the UPS pool
| Interactor |
Type |
Function |
| Ubiquitin |
Substrate |
Activated by adenylation and thioester formation |
| ~35 E2 enzymes |
Downstream |
Receive activated ubiquitin via transthiolation |
| Ubiquitin-like proteins |
Related |
UBA1 is specific for ubiquitin (not SUMO, NEDD8, etc.) |
| UBA6 |
Paralog |
The only other E1 for ubiquitin; handles ~1% of ubiquitination |
| Proteasome |
Functional |
End effector of UBA1-initiated ubiquitination |
Somatic mutations eliminating the cytoplasmic UBA1b isoform (M41T/V/L) cause VEXAS[5]:
- Systemic autoinflammation from UPS failure in myeloid cells
- Treatment: azacitidine, JAK inhibitors, HSCT
- Some patients develop neurological involvement (CNS vasculitis)
- UBA1 activators: Small molecules enhancing UBA1 activity could broadly improve proteostasis
- Gene therapy: AAV-UBA1 for X-linked SMA
- Downstream enhancement: Proteasome activators, autophagy inducers as complementary approaches